Schedule 13G ownership disclosure

Atara Biotherapeutics Inc

Security class unavailable · CUSIP: 046513206

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
180,715
Percent of class
3.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-24-000879
Form type
SC 13G/A
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
Nov 12, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub